CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Bupivacaine-Lidocaine +1 moredrug
Likely dose
Bupivacaine-Lidocaine 35 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05834023
NCT05834023Phase 4Completed

Comparison Between Bupivacaine 0.5% Versus Bupivacaine 0.25% Plus Lidocaine 1% in Ultrasound-guided Infraclavicular Block: a Prospective Randomized Controlled Trial

Hospital de San Carlos Dr. Benicio Arzola Medina·interventional·Posted Apr 27, 2023·Updated Jan 17, 2024

In Brief

A Phase 4 clinical trial evaluating Bupivacaine-Lidocaine and Bupivacaine for Pain, Acute and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

In this study, the investigators will compare two different anesthetic solutions in the infraclavicular block in patients having forearm, wrist, and hand surgery. The solutions will be bupivacaine 0.5% versus bupivacaine 0.25% plus lidocaine 1%, both associated with epinephrine 5 mcg/ml and dexamethasone 4 mg. The main objective of this investigation is to demonstrate that using higher concentrations of bupivacaine alone results in a significant block duration increase compared with the mixture of bupivacaine and lidocaine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChile
Collaborators--

Timeline

Phase 4CompletedFinished
202420252026
First PostedApr 27, 2023
Enrollment StartMay 2, 2023
Primary CompletionDec 29, 2023
Study CompletionJan 5, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.2 years ago

Interventions

Bupivacaine-Lidocainedrug

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg/ml

Bupivacainedrug

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.5% + dexamethasone 4 mg + epinephrine 5 mcg/ml